A patient who was admitted to our hospital to undergo surgery for a dissecting thoracic aneurysm suffered preoperatively from severe acute pancreatitis with pancreatic pseudocysts. Computerized tomography (CT) demonstrated the presence of new fluid collection around the cyst with the absence of pancreatic necrosis. He was given a somatostatin analog (sandostatin), which was effective in decreasing the abdominal symptoms, leukocyte counts, and the serum Creactive/protein level. A CT scan revealed that the pancreatic pseudocyst and peripancreatic fluid collection had disappeared. Although somatostatin has been reported to be ineffective for acute pancreatitis with necrosis, pancreatitis without necrosis may regress after treatment with sandostatin. This is probably due to its suppressive effect on the exocrine function, thus resulting in a decrease of pancreatic juice infiltration.
dissecting aneurysm somatostatin analog pancreatic pseudocyst severe acute pancreatitis
This is a preview of subscription content, log in to check access.
Saitoh Y, Yamamoto M (1991) Evaluation of severity of acute pancreatitis, according to a report of the cooperative national survey in Japan. Int J Pancreatol 9:51–58PubMedGoogle Scholar
Boden G, Sivitz MC, Owen OE et al (1975) Somatostatin suppresses secretin and pancreatic exocrine secretion. Science 190:163–165CrossRefPubMedGoogle Scholar
Raptis S, Schlegel W, Lehmann E et al (1978) Effects of somatostatin on the exocrine pancreas and the release of duodenal hormones. Metabolism 27 (suppl 1): 1321–1328CrossRefPubMedGoogle Scholar
Susini C, Esteve JP, Vaysse N et al (1980) Somatostatin 28: effects on exocrine pancreatic secretion in conscious dogs. Gastroenterology 79:720–724PubMedGoogle Scholar
Gjorup I, Roikjaer O, Andersen B (1992) A double blinded multicenter trial of somatostatin in the treatment of acute pancreatitis. Surg Gynecol Obstet 175:397–400PubMedGoogle Scholar
Choi TK, Mok F, Zhan WH (1989) Somatostatin in the treatment of acute pancreatitis: a prospective randomized controlled trial. Gut 30:223–227CrossRefPubMedGoogle Scholar
Usadel KH, Uberla K, Leuschner U (1985) Treatment of acute pancreatitis with somatostatin: results of the multicenter doubleblind trial. Dig Dis Sci 30:992Google Scholar
Miyasaka Y, Ono K (1996) A case of pancreatic pleural effusion and ascites treated successfully with conservative measures including octreotide and nafamostat mesilate. Nippon Shokakibyo Gakkai Zasshi (Jpn J Gastroenterol) 93:937–941PubMedGoogle Scholar
Yamao K, Nakazawa S (1996) Successful treatment of a large pancreatic pseudocyst with a percutaneous catheter drainage and a somatostatin analogue: report of a case. Nippon Shokakibyo Gakkai Zasshi (Jpn J Gastroenterol) 93:942–946PubMedGoogle Scholar
Beger HG, Kunz R, Bittner R (1987) Prognostic criteria in necrotizing pancreatitis. In: Beger HG, Buchler M (eds) Acute pancreatitis. Springer, Berlin Heidelberg New York Tokyo, pp 198–200Google Scholar